Depth of mesorectal invasion has prognostic significance in T3NO low rectal cancer

Hepato-Gastroenterology

Volumn 56, Issue 89, 2009, Pages 124-127

  Tokoro, Tadao ^a   Okuno, Kiyotaka ^a   Hida, Jin Ichi ^a   Ishimaru, Eizaburo ^a   Ueda, Kazuki ^a   Yoshifuji, Takehito ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Depth of direct spread; Low rectal cancer; Mesorectal fat invasion; Sharp mesorectal excision

Indexed keywords

CARMOFUR; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER LOCALIZATION; CANCER STAGING; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; OVERALL SURVIVAL; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RECTUM CARCINOMA; RECTUM RESECTION; RECURRENT CANCER; REFERENCE VALUE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECTAL NEOPLASMS; RECTUM; SURVIVAL RATE;

EID: 64949197225     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Sobin LH, Wittenkind CH: International union against cancer. TMN classification of malignant tumours. 6th ed. New York: John Wiley Liss, 2002.
2. Miyoshi M, Ueno H, Hashiguchi Y, Mochizuki H: Extent of mesorectal tumor invasion as a prognostic factor after curative surgery for T3 rectal cancer patients. Ann Surg 2006; 243:492-498.
3. Steel MC, Woods R, Mackay JM, Chen F: Extent of mesorectal invasion is a prognostic indication in T3 rectal carcinoma. ANZ J Surg 2002; 72:483-487.
4. Nagtegaal ID, van de Velde CJ, van der Worp E, Kapiteijn E, Quirke P, van Krieken JH: Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol 2002; 20:1729-1734.
5. Willet CG, Badizadegan K, Ancukiewicz M, Shellito PC: Prognostic factors in stage T3N0 rectal cancer: do all patients require postoperative pelvic irradiation and chemotherapy? Dis Colon Rectum 1999; 42:167-173.
6. Merchant NB, Guillem JG, Paty PB, Enker WE, Minsky BD, Quan SH, Wong D, Cohen AM: T3N0 rectal cancer-results following sharp mesorectal excision and no adjuvant therapy. J Gastrointest Surg 1999; 3:642-647.
7. Nissan A, Stojadinovic A, Shia J, Hoos A, Guillem JG, Klimstra D, Cohen AM, Minsky BD, Paty PB, Wong WD: Predictor of recurrence in patients with T2 and early T3, N0 adenocarcinoma of the rectum treated by surgery alone. J Clin Oncol 2006; 24: 4078-4084.
8. Merkel S, Mansmann U, Siassi M, Papadopoulos T, Hohenberger W, Hermanek P: Prognostic in homogeneity in pT3 rectal carcinomas. Int J Colorectal Dis 2001; 16:298-304.
9. Cawthorn SJ, Parums DV, Gibbs NM, A'Hern RP, Caffarey SM, Broughton CIM, Marks CG: Extent of mesorectal spread and involvement of lateral resection margin as prognostic factors after surgery for rectal cancer. Lancet 1990; 335:1055-1059.
10. Nagtegaal ID, van de Velde CJ, Marijnen CA, van Krieken JH, Quirke P: Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol 2005; 23:9257-9264.
11. Bólow S, Christensen IJ, Harling H, Kronborg O, Fenger C, Nielsen HJ: Recurrence and survival after mesorectal excision for rectal cancer. Br J Surg 2003; 90:974-980.
12. Bonadeo FA, Vaccaro CA, Benati ML, Quintana GM, Garione XE, Talenta MT: Rectal cancer - local recurrence after surgery without radiotherapy. Dis Colon Rectum 2001; 44:374-379.
13. Harewood GC, Kumar KS, Clain JE, Levy MJ, Nelson H: Clinical implications of quantification of mesorectal tumor invasion by endoscopic ultrasound: all T3 rectal cancers are not equal. J Gastro Hepatol 2004; 19:750-755.
14. Picon AI, Moore HG, Sternberg SS, Minsky BD, Paty PB, Blumberg D, Quan SH, Wong WD, Cohen AM, Guillem JG: Prognostic significance of depth of gross or microscopic perorectal fat invasion in T3N0M0 rectal cancers following sharp mesorectal excision and no adjuvant therapy. Int J Colorectal Dis 2003; 18:487-492.
15. Law WL, Ho JW, Chan R, Au G, Chu KW: Outcome of anterior resection for stage II rectal cancer without radiation-the role of adjuvant chemotherapy. Dis Colon Rectum 2005; 48:218-226.
16. Stocchi L, Nelson H, Sargent DJ, O'Connell SM, Tepper JE, Krook JE, Beart R Jr: North Central Cancer Treatment Group: Impact of surgical and pathologic variables in rectal cancer: United States community and cooperative group report. J Clin Oncol 2001; 19: 3895-3902.
17. Nelson H, Sergent DJ: Refining multimodal therapy for rectal cancer. N Eng J Med 2001; 345:690-692.
18. Maslekar S, Sharma A, MacDonald A, Gunn J, Monson JRT, Hartley JE: Mesorectal grades predict recurrences after curative resection for rectal cancer. Dis Colon Rectum 2006; 50:168-175.